Altor Bioscience Corporation

Altor BioScience Corporation is a company based in Miramar, Florida, focused on the development of immune-therapeutics for cancer and disease. The company is currently small, with a team of 2 employees. Altor BioScience is dedicated to advancing immunotherapy research, targeting cancers with unmet clinical needs. They are actively participating in oncology immunotherapy initiatives and currently have multiple clinical trials underway. The company is developing a new protein candidate, ALT-803, which has recently been designated for Fast Track Development by the FDA. Altor BioScience is committed to transitioning its early-phase drug candidate to phase 3 development and expanding its product pipeline. They are investing in the expansion of their manufacturing capabilities in El Segundo, California, to support the tech transfer, process improvement, cGMP manufacturing, and product release of their therapeutics. For more information about Altor BioScience Corporation, please visit their website at altorbioscience.com.